{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:49:10Z","timestamp":1792064950518,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05580-2","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:48:27Z","timestamp":1784562507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of adjuvant chemotherapy on survival in stage IIA colon cancer with partial bowel obstruction after propensity score matching"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9374-353X","authenticated-orcid":false,"given":"In Jun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3152-0151","authenticated-orcid":false,"given":"Dong Ha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0035-9000","authenticated-orcid":false,"given":"Kyung-Ha","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7964-5060","authenticated-orcid":false,"given":"Ji Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"5580_CR1","unstructured":"Statistics Korea. Cancer incidence and mortality statistics in Korea. 2024. https:\/\/kostat.go.kr\/board.es?act=view&bid=218&list_no=433106&mainXml=Y&mid=a10301010000. Accessed March 17, 2025."},{"key":"5580_CR2","doi-asserted-by":"publisher","first-page":"7924","DOI":"10.3390\/curroncol31120584","volume":"31","author":"BZ Lin","year":"2024","unstructured":"Lin BZ, Lin CL, Chiang FF, Chen CC, Chen MC, Lin CY, et al. The clinical characteristics of a stage II colorectal cancer T4 tumor: a ten-year single-center research report. Curr Oncol. 2024;31:7924\u201335. https:\/\/doi.org\/10.3390\/curroncol31120584.","journal-title":"Curr Oncol"},{"key":"5580_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70385","volume":"13","author":"P Lou","year":"2024","unstructured":"Lou P, Luo D, Huang Y, Chen C, Yuan S, Wang K. Establishment and validation of a prognostic nomogram for predicting postoperative overall survival in advanced stage III\u2013IV colorectal cancer patients. Cancer Med. 2024;13:e70385. https:\/\/doi.org\/10.1002\/cam4.70385.","journal-title":"Cancer Med"},{"key":"5580_CR4","doi-asserted-by":"crossref","unstructured":"Quasar Collaborative Group, Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007;370:2020\u20139","DOI":"10.1016\/S0140-6736(07)61866-2"},{"key":"5580_CR5","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343\u201351. https:\/\/doi.org\/10.1056\/NEJMoa032709.","journal-title":"N Engl J Med"},{"key":"5580_CR6","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1200\/JCO.21.02538","volume":"40","author":"NN Baxter","year":"2022","unstructured":"Baxter NN, Kennedy EB, Bergsland E, Berlin J, George TJ, Gill S, et al. Adjuvant therapy for stage II colon cancer: ASCO guideline update. J Clin Oncol. 2022;40:892\u2013910. https:\/\/doi.org\/10.1200\/JCO.21.02538.","journal-title":"J Clin Oncol"},{"key":"5580_CR7","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","volume":"31","author":"G Argil\u00e9s","year":"2020","unstructured":"Argil\u00e9s G, Tabernero J, Labianca R, Hochhauser D, Salazar R, Iveson T, et al. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31:1291\u2013305. https:\/\/doi.org\/10.1016\/j.annonc.2020.06.022.","journal-title":"Ann Oncol"},{"key":"5580_CR8","unstructured":"Benson AB, Venook AP, Adam M, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Colon Cancer. Version 1.2025. National Comprehensive Cancer Network; 2025. Accessed March 17, 2025. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?id=1428."},{"issue":"6","key":"5580_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-009-0007-5","volume":"33","author":"JS Kim","year":"2009","unstructured":"Kim JS, Hur H, Min BS, Sohn SK, Cho CH, Kim NK. Oncologic outcomes of self-expanding metallic stent insertion as a bridge to surgery in the management of left-sided colon cancer obstruction: comparison with nonobstructing elective surgery. World J Surg. 2009;33(6):1281. https:\/\/doi.org\/10.1007\/s00268-009-0007-5.","journal-title":"World J Surg"},{"key":"5580_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.914299","volume":"12","author":"JH Lim","year":"2022","unstructured":"Lim JH, Lee WY, Yun SH, Kim HC, Cho YB, Huh JW, et al. Comparison of oncologic outcomes between incomplete obstructive colon cancer and non-obstructive colon cancer by tumor location. Front Oncol. 2022;12:914299. https:\/\/doi.org\/10.3389\/fonc.2022.914299.","journal-title":"Front Oncol"},{"key":"5580_CR11","first-page":"251","volume":"77","author":"P Barillari","year":"1992","unstructured":"Barillari P, Aurello P, De Angelis R, Valabrega S, Ramacciato G, D\u2019Angelo F, et al. Management and survival of patients affected with obstructive colorectal cancer. Int Surg. 1992;77:251\u20135.","journal-title":"Int Surg"},{"key":"5580_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.amjsurg.2013.07.027","volume":"207","author":"R Frago","year":"2014","unstructured":"Frago R, Ramirez E, Millan M, Kreisler E, Del Valle E, Biondo S. Current management of acute malignant large bowel obstruction: a systematic review. Am J Surg. 2014;207:127\u201338. https:\/\/doi.org\/10.1016\/j.amjsurg.2013.07.027.","journal-title":"Am J Surg"},{"key":"5580_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.clcc.2024.04.002","volume":"23","author":"SY Oh","year":"2024","unstructured":"Oh SY, Kim CW, Kim S, Kim MH, Kim YI, Lee JL, et al. Complete obstruction, a real risk factor: a comprehensive study on obstruction in stage IIA colon cancer with propensity score matching analysis. Clin Colorectal Cancer. 2024;23:135-46.e3. https:\/\/doi.org\/10.1016\/j.clcc.2024.04.002.","journal-title":"Clin Colorectal Cancer"},{"key":"5580_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436\u201344. https:\/\/doi.org\/10.1038\/nature07205.","journal-title":"Nature"},{"key":"5580_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/457036b","volume":"457","author":"MA Cancer","year":"2009","unstructured":"Cancer MA. Inflaming metastasis. Nature. 2009;457:36\u20137. https:\/\/doi.org\/10.1038\/457036b.","journal-title":"Nature"},{"key":"5580_CR16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/codi.15479","volume":"23","author":"JV Veld","year":"2021","unstructured":"Veld JV, Beek KJ, Consten ECJ, Ter Borg F, van Westreenen HL, Bemelman WA, et al. Definition of large bowel obstruction by primary colorectal cancer: a systematic review. Colorectal Dis. 2021;23:787\u2013804. https:\/\/doi.org\/10.1111\/codi.15479.","journal-title":"Colorectal Dis"},{"key":"5580_CR17","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1200\/JCO.2015.63.4238","volume":"33","author":"T Andr\u00e9","year":"2015","unstructured":"Andr\u00e9 T, de Gramont A, Vernerey D, Chibaudel B, Bonnetain F, Tijeras-Raballand A, et al. Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the Mosaic study. J Clin Oncol. 2015;33:4176\u201387. https:\/\/doi.org\/10.1200\/JCO.2015.63.4238.","journal-title":"J Clin Oncol"},{"key":"5580_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-023-04541-3","volume":"38","author":"JRE Boeding","year":"2023","unstructured":"Boeding JRE, Elferink MAG, Tanis PJ, de Wilt JHW, Gobardhan PD, Verhoef C, et al. Surgical treatment and overall survival in patients with right-sided obstructing colon cancer\u2014a nationwide retrospective cohort study. Int J Colorectal Dis. 2023;38:248. https:\/\/doi.org\/10.1007\/s00384-023-04541-3.","journal-title":"Int J Colorectal Dis"},{"key":"5580_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11605-022-05516-5","volume":"27","author":"TW Mo","year":"2023","unstructured":"Mo TW, Zhang ZJ, Shi YQ, Xiang HD, Chen YL, Chen ZX, et al. Prognostic implications of endoscopic obstruction in patients with pathological stage II colon cancers: a single-center retrospective cohort study. J Gastrointest Surg. 2023;27:141\u201351. https:\/\/doi.org\/10.1007\/s11605-022-05516-5.","journal-title":"J Gastrointest Surg"},{"key":"5580_CR20","doi-asserted-by":"publisher","first-page":"e258867","DOI":"10.1001\/jamanetworkopen.2025.8867","volume":"8","author":"F Pennisi","year":"2025","unstructured":"Pennisi F, Buzzoni C, Russo AG, Gervasi F, Braga M, Renzi C. Comorbidities, socioeconomic status, and colorectal cancer diagnostic route. JAMA Netw Open. 2025;8:e258867. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.8867.","journal-title":"JAMA Netw Open"},{"key":"5580_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/SLA.0000000000003832","volume":"275","author":"C Sabbagh","year":"2022","unstructured":"Sabbagh C, Manceau G, Mege D, et al. Is adjuvant chemotherapy necessary for obstructing stage II colon cancer? Results from a propensity score analysis of the French Surgical Association Database. Ann Surg. 2022;275:149\u201356. https:\/\/doi.org\/10.1097\/SLA.0000000000003832.","journal-title":"Ann Surg"},{"key":"5580_CR22","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1056\/NEJMoa043116","volume":"352","author":"C Twelves","year":"2005","unstructured":"Twelves C, Wong A, Nowacki MP, Abt M, Burris H, Carrato A, et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med. 2005;352:2696\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa043116.","journal-title":"N Engl J Med"},{"key":"5580_CR23","doi-asserted-by":"publisher","unstructured":"Cassidy J, Twelves C, Van Cutsem E, Hoff P, Bajetta E, Boyer M, et al.; Capecitabine Colorectal Cancer Study Group. First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil\/leucovorin. Ann Oncol. 2002;13:566-75. https:\/\/doi.org\/10.1093\/annonc\/mdf089.","DOI":"10.1093\/annonc\/mdf089."}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05580-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05580-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05580-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:58:33Z","timestamp":1792061913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05580-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5580"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05580-2","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our study was approved by the Institutional Review Board (IRB No.: 2025\u201302-049) of Chungnam National University Hospital. All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments (or comparable ethical standards). The requirement for informed consent was waived owing to the retrospective design of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work the authors used GPT for language editing\/linguistic refinement. After using this tool\/service: the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":4,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the manuscript preparation process","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1445"}}